Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-21

FDA Approved: LANSOPRAZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's original ANDA for lansoprazole, enabling a generic version to be marketed for acid-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (generic) (Lansoprazole)

Snippet

ORIG AP for LANSOPRAZOLE (LANSOPRAZOLE)